David Gionco
2016
In 2016, David Gionco earned a total compensation of $1.5M as Vice President of Finance and Chief Accounting Officer at Stemline Therapeutics, a 50% increase compared to previous year.
Compensation breakdown
| Bonus | $147,293 |
|---|---|
| Option Awards | $715,705 |
| Salary | $294,587 |
| Stock Awards | $296,735 |
| Total | $1,454,320 |
Gionco received $715.7K in option awards, accounting for 49% of the total pay in 2016.
Gionco also received $147.3K in bonus, $294.6K in salary and $296.7K in stock awards.
Rankings
In 2016, David Gionco's compensation ranked 6,403rd out of 14,075 executives tracked by ExecPay. In other words, Gionco earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,403 out of 14,075 | 55th |
Division Manufacturing | 2,363 out of 5,489 | 57th |
Major group Chemicals And Allied Products | 774 out of 1,895 | 59th |
Industry group Drugs | 590 out of 1,538 | 62nd |
Industry Pharmaceutical Preparations | 467 out of 1,176 | 60th |
Source: SEC filing on May 1, 2017.
Gionco's colleagues
We found two more compensation records of executives who worked with David Gionco at Stemline Therapeutics in 2016.